SLC40A1

Across TCGA pan-cancer cohorts, SLC40A1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC40A1 data layer compared with 27 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher SLC40A1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC40A1 expression acts as an unfavorable survival marker.

PDAC and LUAD are the cancer types where SLC40A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Tertile	All	0.143	0.742	.024	11	view →
LUAD	DFS	Median	III,IV	0.330	0.937	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SLC40A1–PDAC (DFS)

Open the PDAC breakdown →